Safety, PK and PD of Novel Nasal Glucagon Formulations (GNPc001)

• Research type

  Research Study

• Full title

  Safety, PK and PD of Novel Nasal Glucagon Formulations (GNPc001)

• IRAS ID

  178752

• Contact name

  Louise Rawcliffe

• Contact email

  Louise.rawcliffe@therakind.com

• Sponsor organisation

  Quotient Clinical

• Eudract number

  2015-001158-13

• Duration of Study in the UK

  0 years, 1 months, 13 days

• Research summary

  Research summary not yet available

• REC name

  Wales REC 1

• REC reference

  15/WA/0144

• Date of REC Opinion

  13 May 2015

• REC opinion

  Further Information Favourable Opinion